Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum United Therapeutics Corp UTHR

United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended... see more

Bullboard (NDAQ:UTHR)

View:
Post by whytestockson Aug 28, 2024 12:47pm

United Therapeutics Corporation to Present at Upcoming Inves

JUST IN: $UTHR United Therapeutics Corporation to Present at Upcoming Investor ConferencesUnited Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, announced today that company ...more  
Post by MikeTesteron Aug 02, 2024 4:48am

United Therapeutics Corp (NASDAQ:UTHR): A Specialized Biotec

https://beyondspx.com/2024/08/01/united-therapeutics-corp-nasdaquthr-a-specialized-biotech-powerhouse-delivering-consistent-growth/
Post by whytestockson Jul 31, 2024 8:02pm

United Therapeutics Corporation Reports Second Quarter 2024

Just In: $UTHR United Therapeutics Corporation Reports Second Quarter 2024 Financial ResultsUnited Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, today announced its financial ...more  
Post by Nibinatoron Oct 30, 2023 8:21am

BUY BUY BUY BUY BUY

With MIRO AQUISITION THIS THING SET TO FLY
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities